Clinical Trials Directory

Trials / Completed

CompletedNCT03898037

Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome, A Pilot Randomized Controlled Trial

Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome in Overweight/Obese Non-pcos Infertility Women With Insulin Resistance , A Pilot Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
Sex
Female
Age
18 Years – 36 Years
Healthy volunteers
Not accepted

Summary

The purpose of pilot trial is to compare the efficacy of lifestyle intervention, metformin intervention, lifestyle combined with metformin intervention in improving assisted reproductive technology in non-polycystic ovary syndrome(pcos) patients with overweight/obesity and insulin resistance compared with conventional clinical education. Subjects who meet the inclusion criteria will be randomized to four groups: lifestyle intervention group, metformin intervention group, lifestyle combined with metformin intervention group, and routine clinical education group. Subjects of above three intervention group will start ovulation stimulation treatment after reach the aim or duration of intervention and routine clinical education group has no intervention. All subjects are treated with the same procedures, including a long ovarian stimulation regimen, oocyte retrieval, and fertilization, followed by a planned transfer of two day-3 embryos. The primary outcome is ongoing pregnancy rate.

Conditions

Interventions

TypeNameDescription
BEHAVIORALweight loss interventionweight loss intervention under the guidance of a dietitian, including: restricted energy balanced diet, aerobic exercise, etc.
DRUGmetformin interventionmetformin intervention with a starting dose of 0.5g bid, and the dose will be adjusted by doctors according to the patient's insulin level and adverse events.

Timeline

Start date
2019-06-13
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2019-04-01
Last updated
2022-08-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03898037. Inclusion in this directory is not an endorsement.